+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Cerebral Oximetry Monitoring Market Report and Forecast 2024-2032

  • PDF Icon

    Report

  • 140 Pages
  • October 2023
  • Region: Global
  • Expert Market Research
  • ID: 5910825
The global cerebral oximetry monitoring market size was valued at USD 217.2 million in 2023, driven by its increased adoption in high-risk surgeries due to the rising awareness of cerebral hypoxia risk across the globe. The market size is anticipated to grow at a CAGR of 7.2% during the forecast period of 2024-2032 to achieve a value of USD 406.2 million by 2032.

Cerebral Oximetry Monitoring: Introduction

Cerebral oximetry is a non-invasive monitoring technique that assesses the oxygen saturation level of blood in the brain's cerebral cortex. Utilizing near-infrared spectroscopy (NIRS) technology, this method provides real-time insights into cerebral oxygenation, aiding clinicians in promptly detecting potential instances of cerebral hypoxia or ischemia.

Often employed in surgical settings, especially during cardiovascular and neurosurgical procedures, cerebral oximetry helps ensure adequate oxygen delivery to the brain, offering a safety net against potential neurological complications. Its continuous monitoring capability is instrumental in facilitating timely interventions, making it a valuable tool in the realm of patient care and critical monitoring.

Key Trends in the Global Cerebral Oximetry Monitoring Market

The global cerebral oximetry monitoring market is witnessing rapid growth, driven by its increased adoption in high-risk surgeries due to the rising awareness of cerebral hypoxia risks. Technological advancements, such as improved sensor designs and the emergence of wearable devices, are pushing the boundaries of traditional applications.

Furthermore, there is a noticeable market expansion in developing countries, spurred by enhanced healthcare infrastructures and growing acknowledgment of the technology's benefits. Regulatory challenges and the need for standardization remain pertinent factors influencing the pace of this market's evolution.

Global Cerebral Oximetry Monitoring Market Segmentation

Market Breakup by Age

  • Adult
  • Paediatric

Market Breakup by Application

  • Cardiac Surgery
  • Vascular Surgery
  • Others

Market Breakup by End User

  • Hospitals
  • Speciality Clinics
  • Ambulatory Surgical Centres
  • Others

Market Breakup by Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

Global Cerebral Oximetry Monitoring Market Overview

The global cerebral oximetry monitoring market represents a pivotal aspect of modern medical technology, focused on assessing the oxygen saturation levels within the brain's cerebral cortex. As a non-invasive method relying on near-infrared spectroscopy (NIRS), it has become an indispensable tool for clinicians, especially during critical surgical procedures. The market's growth is significantly bolstered by the increasing demand in surgeries, especially in cardiovascular and neurosurgical contexts, given the tool's potential in minimizing post-operative complications.

Technological innovations, ranging from enhanced accuracy to wearable device adaptations, further strengthen the market's appeal. Additionally, as developing countries invest more in their healthcare systems and recognize the benefits of such technologies, there is a perceptible expansion in market reach. However, this burgeoning field is not without its challenges, with regulatory standards and the call for device standardization playing a crucial role in its global trajectory.

Global Cerebral Oximetry Monitoring Market: Competitor Landscape

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
  • Medtronic
  • Masimo
  • Edwards Lifesciences Corporation
  • Nonin
  • ISS, Inc.
  • GE Healthcare
  • Hamamatsu Photonics K.K.
  • Terumo Cardiovascular Systems Corporation
  • Mespere LifeSciences
The publisher always strives to provide you with the latest information. The numbers in the article are only indicative and may be different from the actual report.


This product will be delivered within 5-7 business days.

Table of Contents

1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Cerebral Oximetry Monitoring Market Overview
3.1 Global Cerebral Oximetry Monitoring Market Historical Value (2017-2023)
3.2 Global Cerebral Oximetry Monitoring Market Forecast Value (2024-2032)
4 Global Cerebral Oximetry Monitoring Market Landscape
4.1 Global Cerebral Oximetry Monitoring Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Cerebral Oximetry Monitoring Product Landscape
4.2.1 Analysis by Age
4.2.2 Analysis by Application
5 Global Cerebral Oximetry Monitoring Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Cerebral Oximetry Monitoring Market Segmentation
6.1 Global Cerebral Oximetry Monitoring Market by Age
6.1.1 Market Overview
6.1.2 Adult
6.1.3 Pediatric
6.2 Global Cerebral Oximetry Monitoring Market by Application
6.2.1 Market Overview
6.2.2 Cardiac Surgery
6.2.3 Vascular Surgery
6.2.4 Others
6.3 Global Cerebral Oximetry Monitoring Market by End User
6.3.1 Market Overview
6.3.2 Hospitals
6.3.3 Specialty Clinics
6.3.4 Ambulatory Surgical Centers
6.3.5 Others
6.4 Global Cerebral Oximetry Monitoring Market by Region
6.4.1 Market Overview
6.4.2 North America
6.4.3 Europe
6.4.4 Asia Pacific
6.4.5 Latin America
6.4.6 Middle East and Africa
7 North America Cerebral Oximetry Monitoring Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Cerebral Oximetry Monitoring Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Cerebral Oximetry Monitoring Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Cerebral Oximetry Monitoring Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Cerebral Oximetry Monitoring Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 INDIA CDSCO
16.1.4 JAPAN PMDA
16.1.5 Others
17 Supplier Landscape
17.1 Medtronic
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 Masimo
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 Edwards Lifesciences Corporation
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Nonin
17.4.1 Financial Analysis
17.4.2 Financial Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 ISS, Inc.
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 GE Healthcare
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 Hamamatsu Photonics K.K.
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Terumo Cardiovascular Systems Corporation
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 Mespere LifeSciences
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
18 Global Cerebral Oximetry Monitoring Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket

Companies Mentioned

  • Medtronic
  • Masimo
  • Edwards Lifesciences Corporation
  • Nonin
  • ISS Inc.
  • GE Healthcare
  • Hamamatsu Photonics K.K.
  • Terumo Cardiovascular Systems Corporation
  • Mespere LifeSciences

Methodology

Loading
LOADING...